Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Inflammatory Resolution in Cardiometabolic Health and Disease

Key facts

Where
Aarhus, DenmarkSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06390189, who can take part

Where in Denmark

  • Steno Diabetes Center Aarhus, Aarhus University HospitalAarhus, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Aarhus
Trial code
NCT06390189
Record updated
28 June 2024
Original description
The specific aim of this study is to determine molecular pathways that differentiate metabolically healthy vs unhealthy human phenotypes, and to investigate the therapeutic potential of pro-resolving lipids. Investigators will recruit volunteers that are metabolically healthy or unhealthy that fall within three BMI ranges: lean (18.-24.9 kg/m2), overweight (25.0-29.9 kg/m2) and obese (>30.0 kg/m2). Investigators hypothesize that metabolically healthy individuals have a superior endogenous capacity to regulate an inflammatory/resolving response.Read full original descriptionShow less

Inflammatory Resolution in Cardiometabolic Health and Disease - an Aarhus Based Cohort

The specific aim of this study is to determine molecular pathways that differentiate metabolically healthy vs unhealthy human phenotypes, and to investigate the therapeutic potential of pro-resolving lipids. Investigators will recruit volunteers that are metabolically healthy or unhealthy that fall within three BMI ranges: lean (18.-24.9 kg/m2), overweight (25.0-29.9 kg/m2) and obese (>30.0 kg/m2). Investigators hypothesize that metabolically healthy individuals have a superior endogenous capacity to regulate an inflammatory/resolving response.

Inclusion: Informed signed consent has been obtained from the volunteer; The volunteer has a BMI greater than 18.5 kg/m2; Men and women over the age of 18 are included.

Exclusion: An MD determines that the individual is on too many medications to participate; The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw; The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin); The individual uses immunosuppressive drugs (e.g., methotrexate); The individual has been drinking alcohol two days before the study visit; The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication; The study staff contacting a potential participant perceives that the individual has difficulty understanding the information; The individual has some form of chronic inflammation; The individual regularly consumes fish oils (omega 3); The individual has significant gastrointestinal problems; The individual smokes or uses chewing tobacco; The individual has tattoos or body piercings on the forearms and / or the stomach that can affect the examination; The individual does not follow instructions given in the research study.

ClinicalTrials.gov NCT06390189